Evidence map›Paper›PMID 36351212›Full record

ArticleJCO global oncology2022

Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil.

Cristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, Rafael D Paes, Rodrigo Dienstmann, Carlos H E Barrios, Aline C Goncalves, Fanny G A Cascelli, Andreza K B A Souto, Leandro C Oliveira and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Impact of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Reply to R. Freitas-Junior et al.JCO global oncology · 2023
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Cristiano A A ResendeOncoclínicas Brasília, Brasília, Brazil.ORCID 0000-0002-9358-7693
Heloísa M Fernandes CruzOncoclínicas São Paulo, São Paulo, Brazil.
Matheus Costa E SilvaOncoclínicas São Paulo, São Paulo, Brazil.ORCID 0000-0002-2924-627X
Rafael D PaesOncoclínicas São Paulo, São Paulo, Brazil.
Rodrigo DienstmannOncoclínicas São Paulo, São Paulo, Brazil.ORCID 0000-0001-5997-318X
Carlos H E BarriosOncoclínicas Porto Alegre, Porto Alegre, Brazil.ORCID 0000-0001-6021-667X
Aline C GoncalvesOncoclínicas Rio de Janeiro, Rio de Janeiro, Brazil.
Fanny G A CascelliOncoclínicas São Paulo, São Paulo, Brazil.
Andreza K B A SoutoOncoclínicas Brasília, Brasília, Brazil.
Leandro C OliveiraOncoclínicas São Paulo, São Paulo, Brazil.ORCID 0000-0001-6344-3544
Tomás ReinertOncoclínicas Porto Alegre, Porto Alegre, Brazil.ORCID 0000-0003-4715-1415
Diocesio A P AndradeOncoclínicas Ribeirão Preto, Ribeirão Preto, Brazil.ORCID 0000-0003-2715-2197
Mauro P PassosOncoclínicas Brasília, Brasília, Brazil.ORCID 0000-0003-0609-1751
Eduardo C MillenOncoclínicas Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-2113-6324
Felipe ZerwesOncoclínicas Porto Alegre, Porto Alegre, Brazil.ORCID 0000-0002-1643-727X
Paulo L MoraesCentro Oncológico Antonio Ermírio de Moares, São Paulo, Brazil.
Bruno L FerrariOncoclínicas Belo Horizonte, Belo Horizonte, Brazil.
Max S ManoOncoclínicas São Paulo, São Paulo, Brazil.ORCID 0000-0001-5666-5261
Centro de Pesquisas Oncológicas · BRClinics Hospital of Ribeirão Preto · BRHospital São Lucas da PUCRS · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA nationwide lockdown was enforced in Brazil starting in March 2020 because of the COVID-19 pandemic when cancer screening activities were reduced. In this study, we evaluated the impact of the COVID-19 pandemic on breast cancer (BC) diagnosis.

methodsWe extracted data from the medical records of patients age older than 18 years who were diagnosed with BC and started treatment or follow-up in private oncology institutions in Brazil between 2018 and 2021. The primary objective was to compare the stage distribution during the COVID-19 pandemic (2020-2021) with a historical prepandemic control cohort (2018-2019). Early BC was defined as stage I-II and advanced disease as stage IV.

resultsWe collected data for 11,753 patients with an initial diagnosis of BC, with 6,493 patients in the pandemic (2020-2021) and 5,260 patients in the prepandemic period (2018-2019). We observed a lower prevalence of early-stage BC (63.6%

conclusionWe observed a substantial increase in the number of cases of advanced-stage BC in Brazil during the COVID-19 pandemic.

Indexed as

Breast NeoplasmsCOVID-19AdolescentBrazilCommunicable Disease ControlFemaleHumansMiddle AgedNeoplasm StagingPandemics

Identifiers

PMID36351212
PMCPMC10166498
OpenAlexW4308730651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.